Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.67 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.67 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.50 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.50 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.50 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL524689 | 0.83 | HPGD (0.64) | GABRA1GABRB2CA2CYP3A4HPGD | |
| Hydrochloric Acid SCHEMBL6040027 | 0.81 | GABRA1 (0.90) | GABRA1GABRB2CA2CYP3A4HPGD | |
| SCHEMBL29531559 | 0.80 | GABRA1 (1.00) | GABRA1GABRB2CA2CYP3A4HPGD | |
| SCHEMBL43297 | 0.80 | GABRA1 (1.00) | GABRA1GABRB2CA2CYP3A4HPGD | |
| SCHEMBL15485453 | 0.80 | GABRA1 (1.00) | GABRA1GABRB2CA2CYP3A4HPGD | |
| Formaldehyde SCHEMBL27606839 | 0.79 | GABRA1 (0.86) | GABRA1GABRB2CA2CYP3A4HPGD | |
| Benzene SCHEMBL1841233 | 0.78 | GABRA1 (0.95) | GABRA1GABRB2CA2CYP3A4HPGD | |
| Hydrogen Peroxide SCHEMBL28937397 | 0.78 | GABRA1 (0.95) | GABRA1GABRB2CA2CYP3A4HPGD | |
| Ethane SCHEMBL5264203 | 0.78 | GABRA1 (0.95) | GABRA1GABRB2CA2CYP3A4HPGD | |
| SCHEMBL28800546 | 0.78 | GABRA1 (0.95) | GABRA1GABRB2CA2CYP3A4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2874664-B1 | COMPOSITION FOR THERAPEUTIC USE, INCLUDING AN ORGANIC LIPID PHASE AND A RARE-EARTH RADIOISOTOPE COMPLEX | CENTRE EUGENE MARQUIS (FR) | 2019-06-19 | — | — | EP | claimed |
| US-9572770-B2 | Stable topical composition and a process for producing a stable topical composition | EVIDENCE SOLUCÕES FARMACÊUTICAS LTDA EPP (BR) | 2017-02-21 | — | — | US | claimed |
| EP-2874664-A1 | COMPOSITION FOR THERAPEUTIC USE, INCLUDING AN ORGANIC LIPID PHASE AND A RARE- EARTH RADIOISOTOPE COMPLEX | Centre Eugene Marquis (FR) | 2015-05-27 | — | — | EP | claimed |
| WO-2014012997-A1 | COMPOSITION FOR THERAPEUTIC USE, INCLUDING AN ORGANIC LIPID PHASE AND A RARE- EARTH RADIOISOTOPE COMPLEX | CENTRE EUGENE MARQUIS (FR) | 2014-01-23 | — | — | WO | claimed |
| US-20130123220-A1 | Stable Topical Composition and a Process for Producing a Stable Topical Composition | EVIDENCE SOLUÇÕES FARMACÊUTICAS LTDA EPP (BR) | 2013-05-16 | — | — | US | claimed |
| WO-2012009778-A2 | A STABLE TOPICAL COMPOSITION AND A PROCESS FOR PRODUCING A STABLE TOPICAL COMPOSITION | EVIDENCE SOLUÇÕES FARMACÊUTICAS LTDA EPP (BR) | 2012-01-26 | — | — | WO | claimed |
| EP-1705227-A2 | New dyestuffs and colorants with specific carbonyl compounds | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-09-27 | — | — | EP | claimed |
| US-11826452-B2 | Reduction of tooth staining derived from cationic antimicrobials | THE PROCTER & GAMBLE COMPANY (US) | 2023-11-28 | — | — | US | disclosed |
| US-20220257484-A1 | WHOLE MOUTH MALADOR CONTROL BY A COMBINATION OF ANTIBACTERIAL AND DEODORIZING AGENTS | PROCTER & GAMBLE (US) | 2022-08-18 | — | — | US | disclosed |
| US-20220105012-A1 | REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIBACTERIALS | PROCTER & GAMBLE (US) | 2022-04-07 | — | — | US | disclosed |
| US-11253451-B2 | Reduction of tooth staining derived from cationic antibacterials | THE PROCTER & GAMBLE COMPANY (US) | 2022-02-22 | — | — | US | disclosed |
| US-20220047484-A1 | Reduction Of Tooth Staining Derived From Cationic Antimicrobials | PROCTER & GAMBLE (US) | 2022-02-17 | — | — | US | disclosed |
| US-11191709-B2 | Reduction of tooth staining derived from cationic antimicrobials | THE PROCTER & GAMBLE COMPANY (US) | 2021-12-07 | — | — | US | disclosed |
| WO-2003041669-A1 | A COMPOSITION FOR PROMOTING HAIR GROWTH | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2003-05-22 | — | — | WO | disclosed |
| EP-0952852-A1 | STABILIZED HINOKITIOL AND COMPOSITIONS CONTAINING SAME | E-L Management Corp. (US) | 1999-11-03 | — | — | EP | disclosed |
| EP-0952852-A4 | — | — | 1999-11-03 | — | — | EP | disclosed |
| US-5811114-A | COSMETICS OR DRUGS PRESERVED BY MICROCAPSULES CONTAINING HINOKITIOL | E-L MANAGEMENT CORP. (US) | 1998-09-22 | — | — | US | disclosed |
| WO-1997047289-A1 | STABILIZED HINOKITIOL AND COMPOSITIONS CONTAINING SAME | E-L MANAGEMENT CORPORATION (US) | 1997-12-18 | — | — | WO | disclosed |
| EP-0108622-B1 | SYNTHETIC RESIN COMPOSITION AND PROCESS FOR PRODUCING THE SAME | MITSUBISHI RAYON CO., LTD. (JP) | 1988-03-02 | — | — | EP | disclosed |
| US-4563494-A | LANTHANOID COMPOUND | MITSUBISHI RAYON CO., LTD. (JP) | 1986-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11826452-B2 | Reduction of tooth staining derived from cationic antimicrobials | PHOSPHO1, PEF1, DNM1L | GABRA1 4513/4885GABRB2 4676/4885CA2 3092/4885 |
| US-20220047484-A1 | Reduction Of Tooth Staining Derived From Cationic Antimicrobials | PHOSPHO1, PEF1, DNM1L | GABRA1 4513/4885GABRB2 4676/4885CA2 3092/4885 |
| US-20220257484-A1 | WHOLE MOUTH MALADOR CONTROL BY A COMBINATION OF ANTIBACTERIAL AND DEODORIZING AGENTS | OR10J3, HDAC10, RPP30 | GABRA1 3378/4885GABRB2 3523/4885CA2 1273/4885 |
| US-11253451-B2 | Reduction of tooth staining derived from cationic antibacterials | SOD1, ZRANB2, HDAC10 | GABRA1 4722/4885GABRB2 4408/4885CA2 3082/4885 |
| US-20220105012-A1 | REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIBACTERIALS | SOD1, ZRANB2, HDAC10 | GABRA1 4722/4885GABRB2 4408/4885CA2 3082/4885 |
| US-11191709-B2 | Reduction of tooth staining derived from cationic antimicrobials | PHOSPHO1, PEF1, DNM1L | GABRA1 4513/4885GABRB2 4676/4885CA2 3092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.